Sanofi SANASDAQ:SNY
- LAST PRICE57.6300
- TODAY'S CHANGE (%)-0.6300 (-1.0814%)
- Bid / Lots53.0000/ 2
- Ask / Lots58.5900/ 1
- Open / Previous Close57.9500 / 58.2600
- Day Range
- 52 Week Range
- Volume1,943,039
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SNY |
|---|---|---|
| 09:32 ET | 30094 | 57.96 |
| 09:34 ET | 2416 | 57.79 |
| 09:36 ET | 14454 | 57.81 |
| 09:38 ET | 8654 | 57.76 |
| 09:39 ET | 14231 | 57.86 |
| 09:41 ET | 4314 | 57.89 |
| 09:43 ET | 1750 | 57.85 |
| 09:45 ET | 8400 | 57.8 |
| 09:48 ET | 6143 | 57.73 |
| 09:50 ET | 5505 | 57.72 |
| 09:52 ET | 13468 | 57.67 |
| 09:54 ET | 6567 | 57.71 |
| 09:56 ET | 3361 | 57.7 |
| 09:57 ET | 7685 | 57.68 |
| 09:59 ET | 12047 | 57.69 |
| 10:01 ET | 24820 | 57.71 |
| 10:03 ET | 9614 | 57.635 |
| 10:06 ET | 11928 | 57.68 |
| 10:08 ET | 128521 | 57.65 |
| 10:10 ET | 3559 | 57.71 |
| 10:12 ET | 19574 | 57.625 |
| 10:14 ET | 5606 | 57.59 |
| 10:15 ET | 1625 | 57.6 |
| 10:17 ET | 16878 | 57.595 |
| 10:19 ET | 22500 | 57.63 |
| 10:21 ET | 13286 | 57.64 |
| 10:24 ET | 12917 | 57.62 |
| 10:26 ET | 12663 | 57.605 |
| 10:28 ET | 3838 | 57.61 |
| 10:30 ET | 13807 | 57.62 |
| 10:32 ET | 2346 | 57.63 |
| 10:33 ET | 2120 | 57.64 |
| 10:35 ET | 1885 | 57.625 |
| 10:37 ET | 3069 | 57.65 |
| 10:39 ET | 10124 | 57.64 |
| 10:42 ET | 25570 | 57.57 |
| 10:44 ET | 21583 | 57.5967 |
| 10:46 ET | 2147 | 57.675 |
| 10:48 ET | 10729 | 57.69 |
| 10:50 ET | 2325 | 57.68 |
| 10:51 ET | 1300 | 57.76 |
| 10:53 ET | 699 | 57.72 |
| 10:55 ET | 2095 | 57.725 |
| 10:57 ET | 7983 | 57.71 |
| 11:00 ET | 12368 | 57.745 |
| 11:02 ET | 1847 | 57.73 |
| 11:04 ET | 2546 | 57.705 |
| 11:06 ET | 2634 | 57.65 |
| 11:08 ET | 5691 | 57.66 |
| 11:09 ET | 1480 | 57.68 |
| 11:11 ET | 1913 | 57.66 |
| 11:13 ET | 200 | 57.64 |
| 11:15 ET | 11896 | 57.59 |
| 11:18 ET | 12637 | 57.6 |
| 11:20 ET | 2610 | 57.605 |
| 11:22 ET | 400 | 57.6 |
| 11:24 ET | 1970 | 57.53 |
| 11:26 ET | 1550 | 57.4905 |
| 11:27 ET | 4708 | 57.49 |
| 11:29 ET | 5485 | 57.51 |
| 11:31 ET | 29239 | 57.58 |
| 11:33 ET | 14100 | 57.56 |
| 11:36 ET | 21962 | 57.61 |
| 11:38 ET | 10532 | 57.62 |
| 11:40 ET | 8034 | 57.66 |
| 11:42 ET | 410 | 57.65 |
| 11:44 ET | 2006 | 57.56 |
| 11:45 ET | 5530 | 57.63 |
| 11:47 ET | 393 | 57.62 |
| 11:49 ET | 900 | 57.63 |
| 11:51 ET | 5878 | 57.57 |
| 11:54 ET | 1096 | 57.57 |
| 11:56 ET | 2158 | 57.58 |
| 11:58 ET | 2172 | 57.6 |
| 12:00 ET | 950 | 57.6 |
| 12:02 ET | 2242 | 57.6 |
| 12:03 ET | 5140 | 57.62 |
| 12:05 ET | 1034 | 57.6101 |
| 12:07 ET | 2309 | 57.6 |
| 12:09 ET | 8936 | 57.6 |
| 12:12 ET | 2013 | 57.59 |
| 12:14 ET | 2824 | 57.565 |
| 12:16 ET | 3108 | 57.5609 |
| 12:18 ET | 2100 | 57.565 |
| 12:20 ET | 3598 | 57.58 |
| 12:21 ET | 1944 | 57.57 |
| 12:23 ET | 1630 | 57.575 |
| 12:25 ET | 5679 | 57.585 |
| 12:27 ET | 600 | 57.6 |
| 12:30 ET | 3430 | 57.6 |
| 12:32 ET | 3554 | 57.61 |
| 12:34 ET | 1738 | 57.6102 |
| 12:36 ET | 2045 | 57.62 |
| 12:38 ET | 2400 | 57.62 |
| 12:39 ET | 1475 | 57.625 |
| 12:41 ET | 3564 | 57.58 |
| 12:43 ET | 5212 | 57.59 |
| 12:45 ET | 1341 | 57.59 |
| 12:48 ET | 4878 | 57.595 |
| 12:50 ET | 3284 | 57.59 |
| 12:52 ET | 30008 | 57.6 |
| 12:54 ET | 6929 | 57.59 |
| 12:56 ET | 3230 | 57.59 |
| 12:57 ET | 3360 | 57.6 |
| 12:59 ET | 7731 | 57.595 |
| 01:01 ET | 1993 | 57.595 |
| 01:03 ET | 3368 | 57.575 |
| 01:06 ET | 5522 | 57.565 |
| 01:08 ET | 1782 | 57.565 |
| 01:10 ET | 6082 | 57.585 |
| 01:12 ET | 1100 | 57.595 |
| 01:14 ET | 4266 | 57.58 |
| 01:15 ET | 2260 | 57.585 |
| 01:17 ET | 3280 | 57.58 |
| 01:19 ET | 1206 | 57.585 |
| 01:21 ET | 1980 | 57.57 |
| 01:24 ET | 3907 | 57.585 |
| 01:26 ET | 923 | 57.585 |
| 01:28 ET | 1862 | 57.585 |
| 01:30 ET | 2181 | 57.595 |
| 01:32 ET | 3103 | 57.595 |
| 01:33 ET | 1259 | 57.595 |
| 01:35 ET | 1637 | 57.595 |
| 01:37 ET | 3700 | 57.6 |
| 01:39 ET | 1377 | 57.615 |
| 01:42 ET | 3969 | 57.595 |
| 01:44 ET | 3112 | 57.63 |
| 01:46 ET | 1003 | 57.63 |
| 01:48 ET | 2697 | 57.645 |
| 01:50 ET | 1767 | 57.635 |
| 01:51 ET | 2185 | 57.635 |
| 01:53 ET | 2214 | 57.65 |
| 01:55 ET | 4631 | 57.655 |
| 01:57 ET | 4361 | 57.64 |
| 02:00 ET | 1991 | 57.65 |
| 02:02 ET | 9180 | 57.66 |
| 02:04 ET | 5674 | 57.685 |
| 02:06 ET | 3517 | 57.685 |
| 02:08 ET | 1344 | 57.675 |
| 02:09 ET | 1025 | 57.675 |
| 02:11 ET | 4737 | 57.64 |
| 02:13 ET | 4098 | 57.645 |
| 02:15 ET | 8165 | 57.648 |
| 02:18 ET | 3633 | 57.65 |
| 02:20 ET | 2878 | 57.675 |
| 02:22 ET | 3295 | 57.66 |
| 02:24 ET | 17417 | 57.75 |
| 02:26 ET | 9841 | 57.7511 |
| 02:27 ET | 1614 | 57.755 |
| 02:29 ET | 5461 | 57.74 |
| 02:31 ET | 5912 | 57.71 |
| 02:33 ET | 2985 | 57.69 |
| 02:36 ET | 9458 | 57.71 |
| 02:38 ET | 11070 | 57.68 |
| 02:40 ET | 4695 | 57.668 |
| 02:42 ET | 6387 | 57.69 |
| 02:44 ET | 3875 | 57.7 |
| 02:45 ET | 5830 | 57.71 |
| 02:47 ET | 7082 | 57.73 |
| 02:49 ET | 3564 | 57.74 |
| 02:51 ET | 1046 | 57.743661 |
| 02:54 ET | 2814 | 57.755 |
| 02:56 ET | 1829 | 57.77 |
| 02:58 ET | 13471 | 57.79 |
| 03:00 ET | 3743 | 57.79 |
| 03:02 ET | 3274 | 57.745 |
| 03:03 ET | 927 | 57.745 |
| 03:05 ET | 3115 | 57.7322 |
| 03:07 ET | 1153 | 57.74 |
| 03:09 ET | 7315 | 57.725 |
| 03:12 ET | 3525 | 57.7 |
| 03:14 ET | 13641 | 57.725 |
| 03:16 ET | 2405 | 57.73 |
| 03:18 ET | 2809 | 57.73 |
| 03:20 ET | 1633 | 57.74 |
| 03:21 ET | 4969 | 57.725 |
| 03:23 ET | 6082 | 57.75 |
| 03:25 ET | 1643 | 57.74 |
| 03:27 ET | 3585 | 57.75 |
| 03:30 ET | 2215 | 57.73 |
| 03:32 ET | 8105 | 57.72 |
| 03:34 ET | 8369 | 57.74 |
| 03:36 ET | 1810 | 57.73 |
| 03:38 ET | 5901 | 57.72 |
| 03:39 ET | 5867 | 57.77 |
| 03:41 ET | 12104 | 57.805 |
| 03:43 ET | 5406 | 57.8 |
| 03:45 ET | 8522 | 57.825 |
| 03:48 ET | 6752 | 57.805 |
| 03:50 ET | 4829 | 57.805 |
| 03:52 ET | 18510 | 57.81 |
| 03:54 ET | 10213 | 57.865 |
| 03:56 ET | 21670 | 57.82 |
| 03:57 ET | 32961 | 57.705 |
| 03:59 ET | 303526 | 57.63 |
Today
DJ Sanofi Says FDA Approves Sarclisa for Treatment of Blood Cancer Patients, from 4 hours ago by Dow Jones
4 hours ago by Dow JonesPress Release: Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant, from 4 hours ago by Dow Jones
4 hours ago by Dow JonesDupixent(R) (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old, from 15 hours ago by Dow Jones
15 hours ago by Dow JonesPress Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old, from 15 hours ago by Dow Jones
15 hours ago by Dow JonesPress Release: Tolebrutinib demonstrated a 31% delay in time to onset of confirmed disability progression in non-relapsing secondary progressive multiple sclerosis phase 3 study, from 17 hours ago by Dow Jones
17 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sanofi SA | 146.9B | 30.7x | +4.55% |
Pfizer Inc | 168.1B | -63.4x | -7.10% |
GSK plc | 86.2B | 15.7x | +6.39% |
Bristol-Myers Squibb Co | 99.4B | -15.2x | +4.90% |
Bayer AG | 31.6B | -22.2x | --- |
Merck & Co Inc | 297.2B | 21.7x | -43.23% |
Company Information
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Contact Information
- Headquarters
- 46 Avenue de la Grande ArmeePARIS, France 75017
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Frederic Oudea
- Chief Executive Officer, Executive Director, Member of the Executive Committee
- Paul Hudson
- Chief Financial Officer, Member of the Executive Committee
- Francois-Xavier Roger
- Chief People Officer, Executive Vice President, Member of the Executive Committee
- Natalie Bickford
- Executive Vice President, General Counsel, Member of the Executive Committee
- Roy Papatheodorou
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $146.9B |
|---|---|
Revenue (TTM) | $52.9B |
Shares Outstanding | 2.5B |
Dividend Yield | 3.53% |
Annual Dividend Rate | 2.0369 USD |
Ex-Dividend Date | 05-09-24 |
Pay Date | 06-06-24 |
Beta | 0.57 |
EPS | $1.88 |
Book Value | $33.02 |
P/E Ratio | 30.7x |
Price/Sales (TTM) | 2.8 |
Price/Cash Flow (TTM) | 20.2x |
Operating Margin | 13.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
